Table 2.
Cox multivariate regression analysis of epidemiological characteristics and comorbidities associated with death for COVID-19 patients
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | |
| Sex | ||||
| Female | 1.00 | 1.00 | ||
| Male | 1.07 | 1.04–1.09 | 1.22 | 1.18–1.25 |
| Age group, y | ||||
| < 60 | 1.00 | 1.00 | ||
| 60–79 | 3.22 | 3.13–3.31 | 2.20 | 2.11–2.28 |
| ≥ 80 | 6.04 | 5.86–6.22 | 3.85 | 3.68–4.02 |
| CCD + H | ||||
| No | 1.00 | 1.00 | ||
| Yes | 1.23 | 1.20–1.23 | 1.05 | 1.02–1.08 |
| CLD | ||||
| No | 1.00 | 1.00 | ||
| Yes | 1.58 | 1.51–1.65 | 1.38 | 1.31–1.45 |
| DM | ||||
| No | 1.00 | 1.00 | ||
| Yes | 1.14 | 1.11–1.17 | 1.14 | 1.11–1.18 |
| CND | ||||
| No | 1.00 | 1.00 | ||
| Yes | 1.94 | 1.86–2.02 | 1.48 | 1.41–1.55 |
CCD + H = chronic cardiovascular disease plus hypertension; CLD = chronic lung disease; DM = diabetes mellitus; CND = chronic neurological disease. Source: Influenza Epidemiological Surveillance System (SIVEP-GRIPE) Epidemiological Surveillance Center of the State Health Secretary of São Paulo (CVE/SES-SP).